Latest Growth Opportunities News

Genesis Minerals has reported a 29% jump in gold resources to 18.9 million ounces and a 19% rise in reserves to 4.4 million ounces as of December 2025, underpinning its ASPIRE 500 growth strategy with new assets and exploration boosts.

Sports Entertainment Group (SEG) has upgraded its FY26 Underlying EBITDA guidance to a range of $15.5 million to $16.5 million, reflecting broad-based growth and operational efficiencies across its media and events businesses.

Navigator Global Investments (ASX: NGI) is acquiring a US$195 million portfolio of Net Revenue Share interests from Stable Asset Management, broadening its alternative asset manager ecosystem and raising A$145 million via a fully underwritten entitlement offer.

Larvotto Resources extends high-grade gold-antimony-tungsten mineralisation at its Metz Mining Centre, with the Midas Gully lode now stretching over 700m and open at depth, supported by new geophysical data.

InteliCare has locked in its largest-ever $8.8 million contract with mecwacare to deploy its AI-driven platform across 22 aged care homes, while appointing Angus Cameron as CEO to spearhead growth.

Terra Metals has unveiled a significant platinum group metal sulfide system at its Southwest Prospect within the Dante Project, backed by robust assay results and a strong cash position following a recent $85 million capital raise.

Leeuwin Metals continues to expand its Marda Gold Project resource with promising shallow gold intercepts at Evanston and Golden Orb, while assays for additional holes remain pending ahead of May drilling resumption.

BSA Limited recorded a break-even Q3 FY2026 as revenue and EBITDA fell sharply year-to-date due to lost contracts, but the company maintains a solid cash buffer to fund its transition.

Eagle Mountain Mining has finalised a joint venture with Nittetsu Mining for the Oracle Ridge copper project, extinguishing a US$7.25 million loan and securing US$16.5 million in additional funding from Nittetsu.

Medallion Metals has greenlit development at Ravensthorpe following a $50 million loan and environmental approval, while integrating Forrestania assets to underpin a multi-source gold strategy.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Liontown Limited has kicked off early works and long-lead procurement for its Kathleen Valley lithium expansion, ahead of a Final Investment Decision expected by March 2027.